Study to Evaluate Bioavailability of a Single 12 mg Dose of Perampanel for Three Intravenous Infusion Durations Relative to a Single 12 mg Perampanel Oral Tablet in Healthy Subjects
Clinical trial NCT03376997 · COMPLETED
Trial details
- NCT number
- NCT03376997
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-08
- Primary completion
- 2018-02-16
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.